Clinical trials
Tuberculosis clinical trials
Below are recruiting tuberculosis clinical trials, each written for real people, not researchers. We’re tracking 147 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07672405RecruitingPhase 2
Sorfequiline-based treatment for new drug-sensitive TB
This study tests a new medicine called sorfequiline, given in a combination regimen, to treat adults with drug-sensitive TB. It aims to see if sorfequiline can work as well as or better than standard treatment and shorten the time to cure.
Wentworth, DurbanAges 18–65 - NCT07638670Recruiting
How mycobacterial infection affects the immune system
This study examines how different types of mycobacterial infections (including tuberculosis) affect your body's immune response. Researchers will compare immune function across different TB types and drug-resistance patterns to better understand the disease and improve treatment.
NingboAges 18 years+ - NCT07628140Recruiting
Home-Based TB Prevention Treatment in Kenya
This study tests a community-friendly way to deliver TB prevention medicine (called TPT) to people's homes in Kenya. Researchers want to see if bringing screening and treatment to your house—instead of making you go to a clinic—helps more people start and finish TB prevention, which can reduce TB spread in your community.
KisumuAges Any age - NCT06719193RecruitingPhase 2/Phase 3
TB study for all ages in Ethiopia
This trial is testing a new way to find and treat tuberculosis (TB) in communities in Ethiopia. It aims to help people of any age who live in certain areas get better care.
West Arsi Zone, Ormoia Regional StateAges Any age - NCT06338215Recruiting
Moderate drinking vs. abstention advice for adults
This study compares two approaches for adults who drink regularly: advice on drinking in moderation vs. advice to stop drinking entirely. The goal is to see which approach better prevents major diseases and early death over time.
Pamplona, NavarreAges 50–75 - NCT04975178RecruitingPhase 3
Test of a TB vaccine for newborns in sub-Saharan Africa
This Phase 3 study tests whether MTBVAC can safely protect newborn babies from tuberculosis and whether it helps the baby’s immune system learn to fight TB. If you enroll, the goal is to see safety and immune response in real newborn settings in sub-Saharan Africa.
Worcester, Western CapeAges 5 minutes–1 week - NCT07387601Recruiting
Peer education for TB treatment in Ethiopia
This trial tests whether having a peer educator (someone who has been through TB treatment) help you stay on track with your medicines and get better. It is for adults with new, easy-to-treat TB in South Omo and Ari Zone, Ethiopia.
Jinka, Southern EthiopiaAges 18 years+ - NCT06748937RecruitingPhase 2
Testing alpibectir plus ethionamide for new TB
This study tests an experimental oral TB drug called alpibectir given together with ethionamide for people with newly diagnosed lung TB. The goal is to see how well the combination works and if it is safe.
Cape Town, Western CapeAges 18–65 - NCT07313995Recruiting
Digital health tool to help people take TB prevention
This study tests whether a digital health tool can help more people start and complete tuberculosis preventive treatment (TPT). If you live with or have close contact with someone who has drug-sensitive TB and live in the area for at least 4 months, you may be able to join.
Arba Minch, South EthiopiaAges Any age - NCT07271225Recruiting
Ear acupuncture for nausea from TB drugs
This study tests whether ear acupuncture can help reduce nausea and vomiting caused by tuberculosis medications. It is for people who are at least 17 years old, have drug-sensitive or certain types of drug-resistant TB, and feel sick after taking their TB pills.
Jakarta, Jakarta TimurAges 17 years+ - NCT06528418Recruiting
Breath test to find lung diseases
This study uses a simple breath test to detect different lung diseases. By analyzing the chemicals in your breath, researchers hope to find a faster, non-invasive way to diagnose lung conditions. It may be an option if you have a known lung disease and have a recent CT scan.
Guangzhou, GuangdongAges 18–100 - NCT07240259Enrolling by invitation
Using a donated aortic patch to rebuild a child's windpipe
This trial tests a new way to repair a child's windpipe using a piece of donated aorta (a blood vessel) as a patch. It's for children who have severe breathing problems from a narrowed or damaged windpipe and cannot have standard surgery.
TaipeiAges birth–18 years - NCT07234929Recruiting
Chat reminders for follow-up after abnormal chest x-rays
This trial tests if getting reminders through the Zalo chat app helps people complete follow-up tests after an abnormal chest x-ray. It aims to catch lung cancer early in people at higher risk.
Ho Chi Minh City, Ho Chi Minh CityAges 40–62 - NCT07227779RecruitingPhase 2
B-PaLMZ for TB meningitis in people with HIV
This trial tests a combination of TB medicines (B-PaLMZ) for people with HIV who have their first episode of TB meningitis. It aims to find a better treatment option.
KampalaAges 18 years+ - NCT06916962Recruiting
Supporting TB recovery: The UPLIFT trial
This trial is studying if offering extra support to people being treated for tuberculosis (TB) can help them recover and feel better overall. It's for people who have started treatment for drug-sensitive TB and live in certain areas.
Ba Ria Vung TauAges 18 years+ - NCT07170735Recruiting
Measuring TB DNA in blood and urine for diagnosis
This study looks for TB DNA in blood and urine samples to see if it can help diagnose tuberculosis (TB) more quickly. It includes people with active TB, those with a latent (hidden) TB infection, and healthy volunteers without TB.
Hong Kong, Hong KongAges 18 years+ - NCT07155954Recruiting
Super-Resolution Ultrasound to Tell Benign from Malignant Lymph Nodes
This study uses a special high-detail ultrasound technique to better tell if lymph nodes are harmless (benign) or cancerous (malignant). It may help avoid unnecessary biopsies or surgeries in the future.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07119359Recruiting
TB and HIV prevention study for households in Uganda
This study tests whether adding HIV prevention services to routine TB household contact checks can help more people stay healthy. If you or someone you live with has TB, you may be able to join.
KampalaAges 15 years+ - NCT07125274Recruiting
New Sputum-Free Test for TB Diagnosis
This study is testing a new way to diagnose tuberculosis (TB) without needing sputum (phlegm) samples. It aims to find a simpler, faster method for people with possible TB or other lung infections.
HamburgAges 18 years+ - NCT07117370Recruiting
Coach Mpilo app for men with TB and HIV
This study tests a coaching app (Coach Mpilo) to help men in South Africa who are starting or restarting TB treatment, and for those who also have HIV but are not yet on HIV medication. The goal is to see if the app is helpful and usable.
East LondonAges 18 years+ - NCT07073638RecruitingPhase 2
Testing a new TB drug called RESP30TB in people with newly diagnosed TB
This trial tests a new drug, RESP30TB, to see if it is safe, tolerable, and can quickly kill TB bacteria in people with newly diagnosed, rifampicin-susceptible pulmonary TB. You may be eligible if you can produce sputum and meet other health criteria.
Cape Town, BellvilleAges 18–65 - NCT07018076Recruiting
TB treatment study for people who just finished therapy
This study looks for people who have recently completed standard treatment for drug-sensitive TB. Researchers want to check if certain tests can predict long-term health outcomes after treatment.
KampalaAges 12 years+ - NCT06996249Recruiting
Thoracic cancer data collection study
This study collects medical information from people with suspected or confirmed thoracic cancer. The goal is to learn more about these cancers and improve future care.
Ede, GelderlandAges 18 years+ - NCT06984887Enrolling by invitation
New TB tests study in Pakistan for screened patients
This study tests new, easier ways to diagnose TB, like tongue swabs or sputum tests. It is for people who have already had a chest X-ray with a computer-aided detection (CAD) score.
Islamabad, Federal CapitalAges 12 years+
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for tuberculosis?
- Yes. Clin2 currently lists 147 recruiting tuberculosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a tuberculosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a tuberculosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.